TargetRX - Know How.

First in Company's New Suite of Products Leverages Four Forces of Prescribing to Close the Gap Between Intent to Prescribe and Actual NRx

Horsham, Pa. - December 1, 2008 - With the impending "patent cliff," it is more critical than ever to effectively bring new products to market. Pharmaceutical companies need to be armed with powerful insights to make the right decisions when launching new drugs and indications, assessing licensing and co-promotion opportunities and effectively managing their pipelines. In the past, brand teams have been challenged to accurately predict new drug potential and adoption because they have had to rely on a mix of traditional market research, prescribing histories and past experience. Now, TargetRx's LaunchAdvantage^SM is the first solution built for today's health care market that accurately predicts what physicians will actually prescribe versus what they say they will prescribe - providing reliable forecasts that drive optimal resource allocation, effective messaging and positioning and ultimately, successful drug launches. 

Funding Provides Investment Capital to Support New Growth Initiatives

Horsham, PA - April 7, 2008 - TargetRx Inc. today announced that the company has received $9.6M of venture funding led by existing investors Quaker BioVentures, New Enterprise Associates (NEA) and Domain Associates. This infusion of capital will further support the company's plans for growth and the development of innovative new products designed to help the pharmaceutical industry improve sales and marketing effectiveness as well as drive overall business performance.

Craig Scott Assumes Chief Executive Officer Position

Horsham, PA - January 28, 2008 - TargetRx Inc. today announced that Craig H. Scott has been appointed to the role of president and chief executive officer, and he will join the board of directors, effective immediately. Scott assumes the role from Michael J. Luby, company founder who will remain a full-time employee of the company and a member of the board of directors.

Pharmaceutical Sales & Marketing Expert to Present Company's Latest Insights

Horsham, PA - November 2, 2007 - TargetRx today announced that the company's President and CEO Mike Luby will deliver a plenary address at the upcoming Pharmaceutical Executive Marketing & Sales Summit to be held November 4-6, 2007 in Philadelphia.

Analysis Enables Pharmaceutical Companies to Measure and Manage Toward Improved Performance; Boehringer Ingelheim #1 with Primary Care Physicians, Bristol-Myers Squibb #1 with Specialists

Horsham, PA - March 7, 2007 - TargetRx today released the results of its 2007 Sales and Marketing Quality (SMQ) Analysis, the only report to provide pharmaceutical management the ability to measure and manage the impact of their sales and marketing execution on physicians' prescribing behaviors. The product of more than seven years of research and development, the TargetRx 2007 SMQ Analysis offers a paradigm by which companies can measure, monitor and manage the critical components that drive effective sales and marketing that can result in improved market performance.

Pharmaceutical Sales and Marketing Thought Leader to Offer New Strategies for Successful Product Launches

Horsham, PA - November 29, 2006 - TargetRx President and CEO Mike Luby will deliver the keynote address at the upcoming 5th Annual Pharmaceutical Product Launches Summit, to be held December 5-6, 2006. As a keynote presenter, Luby will discuss the actions a company should take prior to the launch of a new drug in order to maximize brand opportunities.

Horsham, PA - November 3, 2006 - TargetRx President and CEO Mike Luby will lead discussion at key pharmaceutical events this November, delivering presentations that will address some of industry's biggest concerns, including the Physician Data Patient Restriction Program and the future of sales and marketing.

Luby will reveal alternatives to traditional pharmaceutical sales and marketing strategies at the Transforming Pharmaceutical Brand Leadership Conference and the Prescription Data Restriction Forum. At each conference, executives from leading pharmaceutical companies including Eli Lilly, AstraZeneca and GlaxoSmithKline will discuss how increased institutional marketing restrictions, an aging consumer base and innovations in physician marketing will shape the future of the pharmaceutical industry. Luby will be delivering the following presentations:

Patented Approach Enables Pharmaceutical Companies to Focus Effort on the Drivers of Prescribing and Improving Effectiveness

Horsham, PA - October 2, 2006 - TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that it has been awarded a patent by the United States Patent and Trademark Office (U.S. Patent #7,080,027), titled "Method and System for Analyzing the Effectiveness of Marketing Strategies." Demonstrating the company's continued commitment to innovation, this newly patented method of predicting prescribing behavior allows TargetRx to provide highly actionable insights that help pharmaceutical companies improve sales and marketing performance.

Pharmaceutical Sales and Marketing Expert Recognized as Driving Force in Life Sciences Industry

Horsham, PA - July 31, 2006 - TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that Mike Luby has been selected by PharmaVOICE as one of the "100 Most Inspiring People in the Life Sciences Industry." PharmaVOICE, a valued resource that delivers the views and insights of executives who are shaping the dynamic life sciences industry, will unveil its second annual PharmaVOICE 100 issue in August.

Luby to detail key sales force drivers of physician prescribing and discuss use of metrics to manage sales force quality and improve brand performance

Horsham, PA - June 9, 2006 - TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that CEO Mike Luby will deliver a keynote presentation at the upcoming Pharmaceutical Executive Marketing & Sales Summit, held June 12-14, 2006 at the Doubletree Hotel in Philadelphia, Pa.

Mike Luby Honored for Outstanding Contributions to Pharmaceutical    Industry and Commitment to Greater Philadelphia Business Community 

Horsham, PA - April 10, 2006 - TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that the Philadelphia Business Journal has selected CEO, President and Co-founder Mike Luby as a 40 Under 40 Award winner. Luby was honored for his role in the development and leadership of TargetRx and for his commitment to the greater Philadelphia business community.

Assessment Based on Sales Force Quality, Rather than Popularity

Abbott Laboratories Ranks #1 with Primary Care Physicians; Genentech Ranks #1 with Specialists

Horsham, PA - March 20, 2006 - TargetRx today launched the 2005 Pharmaceutical Sales Force Quality Analysis,a groundbreaking alternative to conventional surveys that provides senior pharmaceutical executives with an evaluation of the quality of their sales and marketing activities as they relate to actual physician prescribing.

Pharmaceutical Marketing Information Services Company Honored for Significant Industry Contributions and Outstanding Business Performance

Horsham, PA - November 2, 2005 - TargetRx, a pharmaceutical marketing information services company that delivers actionable insights to improve brand performance, today announced it has been selected as the winner of the Growth Company of the Year award in the Life Sciences category of the Eastern Technology Council's Enterprise Awards.

CEO Mike Luby to Discuss How Predictive Sales & Marketing Information Can be Utilized to Drive Brand Performance and Increase Market Share

Horsham, PA - November 1, 2005 - TargetRx, a pharmaceutical marketing information services company that delivers actionable insights to improve brand performance, today announced that CEO Mike Luby will be presenting at the upcoming Pharmaceutical Leadership Forum to be held November 7-8th, 2005 at the Ritz-Carlton in Washington D.C.

Pharmaceutical Marketing Information Company Selected by Eastern Technology Council for Thriving Life Sciences Business and Contributions

Horsham, PA - October 25, 2005 - TargetRx, a pharmaceutical marketing information company that delivers actionable insights to improve brand performance, today announced it has been selected as one of three finalists for the Eastern Technology Council's Enterprise Award in the Life Sciences Growth Company of the Year category.

Luby to Serve as Chair of Salesforce Effectiveness Conference Track;  Provide Practical Techniques for Sales & Marketing Effectiveness

Horsham, PA - September 12, 2005 - TargetRx, a marketing information services company that provides pharmaceutical companies with insights to improve marketing and sales effectiveness, announced today that CEO Michael Luby will be chairing the sales force effectiveness track on Tuesday and Wednesday, September 13th and 14th at the 4th Annual Pharmaceutical Marketing Congress, to be held at the Marriott Philadelphia/Pennsylvania Convention Center. In addition to chairing, Luby will give a presentation on marketing and sales unification on the same track at 2:30 p.m. on Tuesday.

To share expertise regarding how to increase effectiveness across sales and marketing at Eye for Pharma's Marketing ROI USA, June 15 and WBR Pharma Force 2005, June 21

Horsham, PA - June 15, 2005 - TargetRx, a marketing information services company that assists pharmaceutical companies in effectively selling and marketing their products, announced today that CEO Michael Luby will be a presenter at two industry events this month -- Eyeforpharma's 5th Annual Marketing Congress, Marketing ROI USA, on Wednesday, June 15 at the Hilton City Avenue Hotel, Philadelphia, PA and WBR Pharma Force 2005, at the Sheraton Inner Harbor Hotel, Baltimore, MD on Tuesday, June 21. At these conferences, Mr. Luby's presentation will be centered on innovative solutions that help pharmaceutical companies make the leap from marketing and sales quantity to quality.

Pharmaceutical Marketing Information Company Continues Momentum

Horsham, PA - April 22, 2005 - TargetRx , a marketing information services company that assists pharmaceutical companies in effectively selling and marketing their products, announced today that it raised $15 million (U.S.) in Series D funding. This round of financing was led by Quaker BioVentures, with additional investments from new investors Montagu Newhall and Wasatch Advisors, and investments from all previous venture capital investors including New Enterprise Associates (NEA), Domain Associates, and Acacia Venture Partners. The capital will be used to accelerate the Company's growth by expanding its product offerings, which are based on the Company's unique and powerful large-sample normative database of physician attitudes. This will enable TargetRx to enhance its proven ability to deliver actionable solutions to pharmaceutical companies to help them make accurate and timely marketing and sales decisions, ultimately improving the performance of their brands.